BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35154707)

  • 1. Patient with prostatic adenocarcinoma with plasmacytoid features and an aberrant immunohistochemical phenotype diagnosed by biopsy and a mini-review of plasmacytoid features in the genitourinary system: A case report.
    Zacharouli K; Vageli DP; Koukoulis GK; Ioannou M
    Mol Clin Oncol; 2022 Mar; 16(3):67. PubMed ID: 35154707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmacytoid acinar adenocarcinoma of the prostate: a newly described variant of prostate cancer.
    Al-Hussain T; Haffner MC; Altaweel WM; Epstein JI
    Hum Pathol; 2019 Dec; 94():86-91. PubMed ID: 31698007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clear cell urothelial carcinoma of the urinary bladder: a case report and review of the literature.
    Knez VM; Barrow W; Lucia MS; Wilson S; La Rosa FG
    J Med Case Rep; 2014 Aug; 8():275. PubMed ID: 25124389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall.
    Gordetsky J; Epstein JI
    Am J Surg Pathol; 2014 Jul; 38(7):941-5. PubMed ID: 24503758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
    Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI
    Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: report of 21 cases.
    Osunkoya AO; Hansel DE; Sun X; Netto GJ; Epstein JI
    Am J Surg Pathol; 2008 Mar; 32(3):461-7. PubMed ID: 18300803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of prostatic adenocarcinoma with aberrant p63 expression: presentation with detailed immunohistochemical study and FISH analysis.
    Baydar DE; Kulac I; Gurel B; De Marzo A
    Int J Surg Pathol; 2011 Feb; 19(1):131-6. PubMed ID: 20719821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases.
    Zhao J; Epstein JI
    Am J Surg Pathol; 2009 Apr; 33(4):583-90. PubMed ID: 19033862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma.
    Genega EM; Hutchinson B; Reuter VE; Gaudin PB
    Mod Pathol; 2000 Nov; 13(11):1186-91. PubMed ID: 11106075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference.
    Epstein JI; Egevad L; Humphrey PA; Montironi R;
    Am J Surg Pathol; 2014 Aug; 38(8):e6-e19. PubMed ID: 25029122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F; Epstein JI
    Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies.
    Borboroglu PG; Comer SW; Riffenburgh RH; Amling CL
    J Urol; 2000 Jan; 163(1):158-62. PubMed ID: 10604336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The eternal enigma in prostatic biopsy access route.
    Fabiani A; Principi E; Filosa A; Servi L
    Arch Ital Urol Androl; 2017 Oct; 89(3):245-246. PubMed ID: 28969413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.
    Osunkoya AO; Epstein JI
    Am J Surg Pathol; 2007 Sep; 31(9):1323-9. PubMed ID: 17721186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmacytoid urothelial carcinoma of the bladder: histological and clinical features of 5 cases.
    Fritsche HM; Burger M; Denzinger S; Legal W; Goebell PJ; Hartmann A
    J Urol; 2008 Nov; 180(5):1923-7. PubMed ID: 18801525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary seminal vesicle carcinoma: an immunohistochemical analysis of four cases.
    Ormsby AH; Haskell R; Jones D; Goldblum JR
    Mod Pathol; 2000 Jan; 13(1):46-51. PubMed ID: 10658909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mucinous adenocarcinoma of the prostate. A case report and analysis of the literature].
    Watarai Y; Demura T; Togashi M; Ohashi N; Chikaraishi T; Hirano T; Fukazawa Y
    Nihon Hinyokika Gakkai Zasshi; 1994 Aug; 85(8):1276-9. PubMed ID: 7523749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer detection yield in repeated biopsy is independent of the diagnosis of earlier biopsies.
    Grepl M; Student V; Furst T; Furstova J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Dec; 153(4):297-302. PubMed ID: 20208971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate.
    Stone NN; Stock RG; Parikh D; Yeghiayan P; Unger P
    J Urol; 1998 Nov; 160(5):1722-6. PubMed ID: 9783940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.